3.36% 0.38

Stoke Therapeutics Inc (STOK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Stoke Therapeutics Inc Azioni (STOK) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	50.46% 4.216	2.802	3.308	-2.481	5.152
Operating Expenses	0.62% 32.59	32.39	30.54	30.78	29.84
Benefits Costs and Expenses	2.79% 30.59	29.76	-	-	27.70
Costs And Expenses	2.79% 30.59	29.76	30.54	30.78	27.70
Operating Income/Loss	4.10% -28.37	-29.59	-27.23	-33.26	-24.69
Nonoperating Income/Loss	23.97% 1.998	2.628	2.692	2.608	2.145
Income/Loss From Continuing Operations Before Tax	2.17% -26.37	-26.96	3.308	-30.65	-22.55
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	2.17% -26.37	-26.96	-24.54	-30.65	-22.55
Net Income/Loss	2.17% -26.37	-26.96	-24.54	-30.65	-22.55
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	14,135% 46.25	0.3249	44.27	44.19	42.54
Diluted Average Shares	14,135% 46.25	0.3249	44.27	44.19	42.54
Basic Earnings Per Share	5.00% -0.57	-0.60	-0.55	-0.69	-0.53
Diluted Earnings Per Share	5.00% -0.57	-0.60	-0.55	-0.69	-0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%